Search
Medpace Holdings Inc
MEDPAdd to Watchlist
460.200USD
+3.110+0.68%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
13.14BMarket Cap
28.37P/E TTM
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
By BusinessUSD
Name
Revenue
Proportion
Oncology
747.59M
29.55%
Metabolic
744.96M
29.44%
Other
408.55M
16.15%
Central Nervous System
254.84M
10.07%
Cardiology
239.37M
9.46%
AVAI
134.94M
5.33%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Oncology
747.59M
29.55%
Metabolic
744.96M
29.44%
Other
408.55M
16.15%
Central Nervous System
254.84M
10.07%
Cardiology
239.37M
9.46%
AVAI
134.94M
5.33%
